MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹5,664 Cr | ₹2,120 Cr | ₹1,863 Cr | ₹2,623 Cr | ₹1,353 Cr |
What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹5,664 Cr |
| Mar2024 | ₹2,120 Cr |
| Mar2023 | ₹1,863 Cr |
| Mar2022 | ₹2,623 Cr |
| Mar2021 | ₹1,353 Cr |
How is Total Current Liabilities of MANKIND PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5,664 Cr | 167.18 | |
| Mar2024 | ₹2,120 Cr | 13.77 | |
| Mar2023 | ₹1,863 Cr | -28.98 | |
| Mar2022 | ₹2,623 Cr | 93.84 | |
| Mar2021 | ₹1,353 Cr | - | |
Compare Total Current Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹85,344.3 Cr | -7.9% | 0.4% | -5.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,535.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -7.9% |
0.4% |
-5.4% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses